<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05045209</url>
  </required_header>
  <id_info>
    <org_study_id>13451</org_study_id>
    <nct_id>NCT05045209</nct_id>
  </id_info>
  <brief_title>Virtual Exercise Rehabilitation Treatment Program for Post Exacerbation of Chronic Obstructive Pulmonary Disease</brief_title>
  <acronym>VERTEX</acronym>
  <official_title>Virtual Exercise Rehabilitation Treatment Program for Post Exacerbation of Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Joseph's Healthcare Hamilton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boeringer Ingelheim</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Joseph's Healthcare Hamilton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory rehabilitation is an intervention proven to improve quality of life in those with&#xD;
      chronic lung disease but access remains poor. The investigators will assess the feasibility&#xD;
      and acceptability of a virtual platform for respiratory rehabilitation as an alternative to&#xD;
      in person rehabilitation. The aim is to use the technology in those post admission with COPD&#xD;
      where access has been even more of a challenge as during this period patients find it&#xD;
      difficult to access an out patient program due to their frailty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      People living with lung disease struggle with activities. An exercise program can help but&#xD;
      these programs are limited and are hard to get to and generally have a long wait list. The&#xD;
      investigators will offer exercise and education through a tablet with internet provided 2&#xD;
      times per week for 10 weeks for patients admitted to hospital with a worsening of their COPD.&#xD;
      Patients will work with a trained therapist for the exercise sessions and with the team for&#xD;
      the education sessions. The investigators will assess outcomes on functional and quality of&#xD;
      life improvements as well as feasibility and scalability of the technology.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 minute walk test distance</measure>
    <time_frame>1 year</time_frame>
    <description>The distance walked during the 6 minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>1-MSTST</measure>
    <time_frame>1 year</time_frame>
    <description>One-minute sit to stand test</description>
  </primary_outcome>
  <other_outcome>
    <measure>Daily activity levels</measure>
    <time_frame>1 year</time_frame>
    <description>Measured by step counts</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Virtual rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Virtual pulmonary rehabilitation will be provided by a tablet with connection to a physiotherapist for monitored exercise sessions with educational videos provided on the tablet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Virtual rehabilitation</intervention_name>
    <description>Patient who are assigned to this group will receive virtual rehabilitation</description>
    <arm_group_label>Virtual rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  minimum age of 18 years&#xD;
&#xD;
          -  maximum age of 90 years&#xD;
&#xD;
          -  diagnosis of COPD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inability to perform exercise&#xD;
&#xD;
          -  severe debilitating conditions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Natya Raghavan, MDCM</last_name>
    <phone>905-521-2100</phone>
    <phone_ext>44548</phone_ext>
    <email>raghanat@hhsc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Josephs' Hospital, Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Nima Makhdami</last_name>
      <phone>6475321431</phone>
      <email>makhdamn@mcmaster.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 5, 2021</study_first_submitted>
  <study_first_submitted_qc>September 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Joseph's Healthcare Hamilton</investigator_affiliation>
    <investigator_full_name>Natya Raghavan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

